Cava is the IBD Stock Of The Day as it hugs a short-term support level while eyeing both an early entry and a more-traditional buy point. Cava stock continues its red-hot run after an August earnings beat-and-raise, near post-IPO highs. Cava stock packs a punch, too, having nearly tripled year to date.